KK
AUPH icon

KLP Kapitalforvaltning’s Aurinia Pharmaceuticals AUPH Stock Holding History

KLP Kapitalforvaltning’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$652K Buy
44,000
+2,300
+6% +$33.6K ﹤0.01% 1280
2025
Q4 		$665K Buy
41,700
+19,300
+86% +$274K ﹤0.01% 1265
2025
Q3 		$248K Hold
22,400
– – ﹤0.01% 1732
2025
Q2 		$190K Hold
22,400
– – ﹤0.01% 1807
2025
Q1 		$180K Hold
22,400
– – ﹤0.01% 1794
2024
Q4 		$201K Buy
+22,400
New +$183K ﹤0.01% 1819

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KLP Kapitalforvaltning's AUPH Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its Aurinia Pharmaceuticals (AUPH) stake by 5.5% in Q1 2026, buying an estimated $33.6K and bringing the position to 44,000 shares worth $652K. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

KLP Kapitalforvaltning first reported a position in AUPH in Q4 2024 and has held it in 6 quarters since. The position peaked at $665K in Q4 2025. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • KLP Kapitalforvaltning held 44,000 shares of Aurinia Pharmaceuticals worth $652K as of Q1 2026.
  • KLP Kapitalforvaltning bought 2,300 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $33.6K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1280 holding.
  • KLP Kapitalforvaltning first reported a position in Aurinia Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's Aurinia Pharmaceuticals position peaked at $665K in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.